CorMedix Inc.
CRMD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $43,472 | $0 | $65 | $191 |
| % Growth | – | -100% | -65.7% | – |
| Cost of Goods Sold | $3,191 | $206 | $4 | $149 |
| Gross Profit | $40,282 | -$206 | $62 | $42 |
| % Margin | 92.7% | – | 94.3% | 22% |
| R&D Expenses | $3,942 | $13,155 | $10,680 | $13,133 |
| G&A Expenses | $29,959 | $0 | $0 | $0 |
| SG&A Expenses | $58,696 | $35,597 | $20,006 | $16,347 |
| Sales & Mktg Exp. | $28,737 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $62,638 | $48,752 | $30,686 | $29,480 |
| Operating Income | -$22,356 | -$48,958 | -$30,624 | -$29,438 |
| % Margin | -51.4% | – | -46,819.9% | -15,417.5% |
| Other Income/Exp. Net | $3,032 | $2,619 | $337 | -$23 |
| Pre-Tax Income | -$19,325 | -$46,339 | -$30,287 | -$29,460 |
| Tax Expense | -$1,395 | $0 | -$586 | -$1,250 |
| Net Income | -$17,930 | -$46,339 | -$29,702 | -$28,210 |
| % Margin | -41.2% | – | -45,409.9% | -14,774.7% |
| EPS | -0.3 | -0.91 | -0.74 | -0.75 |
| % Growth | 67% | -23% | 1.3% | – |
| EPS Diluted | -0.3 | -0.91 | -0.74 | -0.75 |
| Weighted Avg Shares Out | 58,872 | 50,903 | 40,137 | 37,614 |
| Weighted Avg Shares Out Dil | 58,872 | 50,903 | 40,274 | 37,666 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2,579 | $2,682 | $326 | $14 |
| Interest Expense | $36 | $0 | $27 | $16 |
| Depreciation & Amortization | $310 | $71 | $209 | $177 |
| EBITDA | -$18,979 | -$46,234 | -$30,052 | -$29,376 |
| % Margin | -43.7% | – | -45,945.1% | -15,385.1% |